Purple (NASDAQ:PRPL) Misses Q2 CY2026 Sales Expectations

Purple (NASDAQ:PRPL) reported Q2 CY2026 revenue of $98.27 million, down 6.5% year on year, missing market expectations. Non-GAAP adjusted EPS was -$1.52, better than analysts’ consensus. For next quarter, management guided revenue to $430 million at the midpoint. The article also notes negative operating margin and ongoing revenue decline.

Original reporting
Published Aug 10, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Purple (NASDAQ:PRPL) Misses Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$PRPLNeutralMed
01

Why it matters

Q2 revenue missed and profitability remains weak, but the company’s next-quarter revenue guidance (midpoint $430M) is far above consensus estimates, which can materially shift near-term expectations and positioning.

02

Market read

This is a results-and-guidance update that can drive estimate revisions: EPS beat versus revenue miss, plus an unusually high next-quarter revenue outlook.

03

What to watch

The article highlights operating margin at -4.3% in Q2 and negative adjusted EPS, so traders may focus more on cash burn and cost structure than the revenue guide alone.

Relevance 8/10Novelty 6/10Timing: after-hours/overnight following Q2 CY2026 results

Background

Purple is a sleep and home comfort retailer; the article frames Q2 CY2026 as continued progress on controllables despite challenging industry conditions.

Company-level read

Ticker impact

$PRPLNeutralMedium confidence
Context

Purple reported Q2 CY2026 revenue of $98.27M, down 6.5% YoY, missing expectations, while guiding next-quarter revenue to $430M midpoint.

Expected impact

Near-term volatility likely, with traders weighing the revenue miss against the outsized next-quarter revenue outlook.

Evidence & confidence

The article provides concrete Q2 results (revenue, adjusted EPS) and a specific next-quarter revenue midpoint guide, which can drive revisions to near-term estimates despite weak profitability metrics.

Market effects

Consumer discretionary bedding demand signals remain soft, but a sharp guide could temporarily lift sentiment around select retailers with turnaround narratives.

No specific regional demand or macro linkage provided.

No direct global supply-chain or international demand details included.

Counterpoint

The next-quarter revenue guide may be difficult to underwrite given the company’s multi-year revenue decline and still-negative operating margins.

Key entities

  • Purple Innovation

    Reported Q2 CY2026 revenue of $98.27M (down 6.5% YoY) and guided next-quarter revenue to $430M midpoint.

  • Rob DeMartini

    CEO quoted on progress despite missing top-line expectations.

Related articles

$PRPLMedAI 8/10

Why Purple (PRPL) Stock Is Trading Lower Today

Purple (PRPL) shares fell 24.6% after the company reported Q2 revenue of $98.27 million, down 6.5% year over year and below Wall Street expectations. Adjusted EPS was a loss of $1.52, better than forecast. Purple kept full-year revenue guidance around $430 million, but investors focused on the quarterly sales miss.

$PRPLMed

Purple Innovation Reports Second Quarter 2026 Results

Purple Innovation, Inc. (PRPL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Purple Innovation Reports Second Quarter 2026 Results Showroom Revenue Up 16.6% and Comparable Revenue Up 18% GAAP Net Loss of $3.2 Million in the Second Quarter Adjusted EBITDA Improves $4.4 Million to $2.1 Million Regains Compliance with Nasdaq Minimum Bid Price Re

$LWHighAI 8/10

LW Q3 Deep Dive: Stable Volumes and Cost Initiatives Offset Margin Compression

Lamb Weston reported Q3 revenue of $1.67B, beating estimates, but EPS missed at $0.21. Adjusted EBITDA beat by 9.1%. Full-year EPS guidance beats estimates by 9.7%, while EBITDA is in line. Operating margin fell to 5.8% from 9.4% YoY. The company cited stable volumes, cost savings, and North America growth, but faced international challenges. Management emphasized innovation, cost discipline, and pricing power to offset inflation.

$MRVLMedAI 8/10

Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.

Marvell Technology (MRVL) projected fiscal 2028 revenue of $20B and fiscal 2031 revenue between $70B-$90B, up from $8.2B in fiscal 2026. Management cited market growth and increased long-term targets. Shares rose to around $290, trading at 43x expected fiscal 2028 earnings. The company's operating margin is expected to reach 38%-40% by fiscal 2028.